A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: alteration (35), improvement (317), rectification (3), modification (628), amendment (671), adjustment (674)

UHS complaint against The Sunday Times upheld by press watchdog

Description
The Independent Press Standards Organisation (IPSO) recently upheld a complaint made by the trust about an article printed in The Sunday
Url
/AboutTheTrust/Newsandpublications/Latestnews/2018/July-2018/UHS-complaint-against-The-Sunday-Times-upheld-by-press-watchdog.aspx

Wessex Diabetes Network - Individual health care plan - Injections

Description
Individual Health Care Plan � Educational Setting FOR PUPILS WITH DIABETES Name: DOB: School: Year Group: Date of Plan: Inser
Url
/Media/UHS-website-2019/Docs/Services/Child-health/Diabetes/Wessex-Diabetes-Network-Individual-health-care-plan-Injections.pdf

ACCORD-2 example sub-protocol

Description
CONFIDENTIAL ACCORD-2-002 - Sub protocol for Bemcentinib (Amendment 01) TITLE PAGE Master Protocol Title: ACCORD-2: A Multicentre, S
Url
/Media/Southampton-Clinical-Research/COVID-19/ACCORD/ACCORD-2-example-sub-protocol.pdf

Press release: Southampton surgeons trial new "train track" spinal implant

Description
Surgeons in Southampton are trialling a pioneering "train track" implant that could transform treatment for patients with a severe spinal condition
Url
/AboutTheTrust/Newsandpublications/Latestnews/2018/May-2018/Press-release-Southampton-surgeons-trial-new-train-track-spinal-implant.aspx

BEACON protocol v8.0 07Mar2023 signed

Description
A randomised phase IIb trial of BE AC v izumab added to Temozolomide O ± Irin tecan for children with N refractory/rel
Url
/Media/UHS-website-2019/Docs/PaediatricOncology/beacon-protocol-v8.0-07mar2023-signed.pdf

Lenalidomide-RituximabIV/SC

Description
Chemotherapy Protocol LYMPHOMA LENALIDOMIDE-RITUXIMAB (IV/SC) There are multiple versions of this protocol in use. Please ensure you have the correct protocol f
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Lenalidomide-RituximabIVSC.pdf

Lenalidomide-Rituximab IV

Description
Chemotherapy Protocol LYMPHOMA LENALIDOMIDE-RITUXIMAB (IV) There are multiple versions of this protocol in use. Please ensure you have the correct protocol for
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Lenalidomide-Rituximab-IV.pdf

MyelomaBortezomib IV DexamethasonePabinostatThalidomide 21day Ver1.1

Description
Chemotherapy Protocol MULTIPLE MYELOMA BORTEZOMIB (IV)-DEXAMETHASONE-PANOBINOSTAT-THALIDOMIDE Regimen (21 d
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaBortezomib-IV-DexamethasonePabinostatThalidomide-21day-Ver1.1.pdf

MyelomaBortezomib SC DexamethasonePabinostatThalidomide 21day Ver1.1

Description
Chemotherapy Protocol MULTIPLE MYELOMA BORTEZOMIB (SC)-DEXAMETHASONE-PANOBINOSTAT-THALIDOMIDE Regimen (21 d
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaBortezomib-SC-DexamethasonePabinostatThalidomide-21day-Ver1.1.pdf

MyelomaBortezomib SC DexamethasonePabinostat 28 day

Description
Chemotherapy Protocol MULTIPLE MYELOMA BORTEZOMIB (SC)-DEXAMETHASONE-PANOBINOSTAT (28 day) Regimen • Multip
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaBortezomib-SC-DexamethasonePabinostat-28-day.pdf
1 to 10 of 36
Previous 1 2 3 4 Next